The apolipoprotein E (APOE) gene and the risk of diabetic nephropathy (DN): a meta-analysis in East Asian populations

1. Ha TS, Duraisamy S, Faulkner JL, Kasinath BS. Regulation of glomerular endothelial cell proteoglycans by glucose. J Korean Med Sci. 2004;19:245-52.10.3346/jkms.2004.19.2.245Open DOISearch in Google Scholar

2. Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S, et al. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Am J Kidney Dis. 1998;31:666-73.10.1053/ajkd.1998.v31.pm9531184Open DOISearch in Google Scholar

3. Leiva E, Mujica V, Elematore I, Orrego R, Diaz G, Prieto M, et al. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients. Diabetes Res Clin Pract. 2007;78:196-201.10.1016/j.diabres.2007.03.018Open DOISearch in Google Scholar

4. Rippin JD, Patel A, Bain SC. Genetics of diabetic nephropathy. Best Pract Res Clin Endocrinol Metab. 2001;15:345-58.10.1053/beem.2001.0150Open DOISearch in Google Scholar

5. Jandeleit-Dahm K, Cao Z, Cox AJ, Kelly DJ, Gilbert RE, Cooper ME. Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl. 1999;71:S31-6.10.1046/j.1523-1755.1999.07109.xSearch in Google Scholar

6. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetes Metab. 2000;26:254-64.Search in Google Scholar

7. Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J. Coinheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Mol Cell Biochem. 2003;254:353-8.10.1023/A:1027364121738Search in Google Scholar

8. Horita K, Eto M, Makino I. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis. 1994;107:203-11.10.1016/0021-9150(94)90021-3Search in Google Scholar

9. Ha SK, Park HS, Kim KW, Kim SJ, Kim DH, Kim JH, et al. Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus. Nephrol Dial Transplant. 1999;14:2144-9.10.1093/ndt/14.9.214410489223Search in Google Scholar

10. Boizel R, Benhamou PY, Corticelli P, Valenti K, Bosson JL, Halimi S. ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM? Nephrol Dial Transplant. 1998;13:72-5.10.1093/ndt/13.1.72Search in Google Scholar

11. Ilhan N, Kahraman N, Seckin D, Colak R. Apo E gene polymorphism on development of diabetic nephropathy. Cell Biochem Funct. 2007;25:527-32.10.1002/cbf.134816933203Open DOISearch in Google Scholar

12. Joss N, Jardine A, Gaffney D, Boulton-Jones JM. Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Exp Nephr. 2005; 101:e127-33.10.1159/00008757716113584Search in Google Scholar

13. Li S, Li L, Li K, Qi X, Hoekema D, Liu H, et al. Association of adipose most abundant transcript 1 gene (apM1) with type 2 diabetes mellitus in a Chinese population: a meta-analysis of case-control studies. Clin Endocrinol (Oxf). 2008;68:885-9.10.1111/j.1365-2265.2007.03114.x17980008Open DOISearch in Google Scholar

14. Zhang XT, Zhou DJ, Li H, Yu L, Fan YX. Study on apolipoprotein E polymorphism in type diabetes mellitus patients with nephropathy. Chinese J Nephrol. 1999;15:77-81.Search in Google Scholar

15. Dai QF, Wen YH. A study on the relationship between apo E sevels and genotypes in diabetic-nephropathy.Modern J Integr Tradit Chin and West Med. 2000;9: 2321-22.Search in Google Scholar

16. Shen HL, Liu LM, Xiang KS, Long CM, Weng Q, Xu J. Relationship between ApoE gene polymorphism and type 2 diabetes mellitus with its nephropathy in Chinese. Chinese J Diabetes. 2002;10:4-6.Search in Google Scholar

17. Zhang L, Zhu DF, Li Y, Yang MG. Study on apolipoprotein E polymorphism of type 2 diabetes mellitus with nephropathy. Acta Universitatis Medicinalis Anhui. 2002;37:286-89.Search in Google Scholar

18. Liu SY, Ruan XY. The association between apolipoprotein E genetic polymorphism and type 2 diabetes mellitus with nephropathy (in chinese). Chinese J Nephrol. 2004;20:295-96.Search in Google Scholar

19. Xiong B, Ning YY, Zhu XZ. Relativity between apolipoprotein E, fatty acid binding 2 polymorphism and type 2 diabetes mellitus patients with nephropathy. Clin Focus. 2005;20:367-70.Search in Google Scholar

20. Hua F, Liu WQ, Hu WL, Tang Y. Studies of the association apolipoprotein E genetic polymorphism and type 2 diabetes mellitus with nephropathy (author translation). Suzhou Univ J Med Sci. 2006;26:837-38.Search in Google Scholar

21. Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, et al. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy. Clin Genet. 2006;70:20-8.10.1111/j.1399-0004.2006.00628.x16813599Search in Google Scholar

22. Guo Q, Liu J. Association of Apo-E gene polymorphism with biochemical and lipid metabolism parameters in patients with diabetic nephropathy of Hui and Han populations in Gansu Province. Chinese J Endocr Metab. 2006;22:333-37.Search in Google Scholar

23. Zhang GW, Zhang AZ, Xu ZF. Relationship between apolipoprotein E genetic polymorphism and diabetic nephropathy in chinese populations (in chinese). Zhejiang J Clin Med. 2007;9:735-36.Search in Google Scholar

24. Pan SZ, Chen XJ, Yang LY, Lin JY, Xu J. Relationship between PON2, ApoE gene polymorphisms and type 2 diabetic nephropathy. China Medicine. 2007;2:385-88.Search in Google Scholar

25. Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis. 2002;40: 243-51.10.1053/ajkd.2002.3450212148096Search in Google Scholar

26. Araki S, Koya D, Makiishi T, Sugimoto T, Isono M, Kikkawa R, et al. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Diabetes Care. 2003; 26:2416-20.10.2337/diacare.26.8.241612882872Open DOISearch in Google Scholar

27. Kwon MK, Rhee SY, Chon S, Oh S, Woo JT, Kim SW, et al. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77 (Suppl 1):S228-32.10.1016/j.diabres.2007.03.00917624465Search in Google Scholar

28. Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M, et al. Apolipoprotein E polymorphism and hyperlipemia in type II diabetics. Diabetes. 1986; 35:1374-82.10.2337/diab.35.12.13743770314Search in Google Scholar

29. Mazzone T. Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr Opin Lipidol. 1996;7:303-7.10.1097/00041433-199610000-000088937521Open DOISearch in Google Scholar

30. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB, Jr. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986;78: 815-21.10.1172/JCI1126454236803745440Open DOISearch in Google Scholar